1. MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8
   Hui Tong et al, 2020, Aging CrossRef
2. Approach to a Patient with Peritoneal Metastases with Unknown Primary Site: Focus on Histopathological Evaluation
   Aditi Bhatt et al, 2020, Pathology of Peritoneal Metastases CrossRef
3. PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities
   Natalia Gorbokon et al, 2024, Virchows Archiv CrossRef
4. Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high‐grade serous carcinoma from ascites
   Simona Miceska et al, 2023, Cancer Cytopathology CrossRef
5. Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells
   Ravneet Chhabra et al, 2021, Scientific Reports CrossRef
6. A Case Report of Pseudomyxoma Peritonei Arising From Primary Mucinous Ovarian Neoplasms
   Reuben Joseph et al, 2022, Cureus CrossRef
7. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid
   Maximilian Lennartz et al, 2023, Scientific Reports CrossRef
8. Oncogenes in high grade serous adenocarcinoma of the ovary
   Pacharla Manasa et al, 2020, Genes & Cancer CrossRef
9. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review
   Aditi Bhatt et al, 2023, Indian Journal of Surgical Oncology CrossRef
10. PAX8, an Emerging Player in Ovarian Cancer
    Priyanka Gokulnath et al, 2021, Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies CrossRef
11. Paired-Box Gene 8 (PAX8) and Its Association With Epithelial Carcinomas
    Khalid Khizer et al, 2021, Cureus CrossRef
12. PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far
    Tina Di Palma et al, 2022, OncoTargets and Therapy CrossRef